These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22848099)

  • 1. Human antibody response to Aedes aegypti saliva in an urban population in Bolivia: a new biomarker of exposure to Dengue vector bites.
    Doucoure S; Mouchet F; Cournil A; Le Goff G; Cornelie S; Roca Y; Giraldez MG; Simon ZB; Loayza R; Misse D; Flores JV; Walter A; Rogier C; Herve JP; Remoue F
    Am J Trop Med Hyg; 2012 Sep; 87(3):504-10. PubMed ID: 22848099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
    Elanga Ndille E; Doucoure S; Poinsignon A; Mouchet F; Cornelie S; D'Ortenzio E; DeHecq JS; Remoue F
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005109. PubMed ID: 27906987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human IgG antibody response to Aedes aegypti Nterm-34 kDa salivary peptide as an indicator to identify areas at high risk for dengue transmission: a retrospective study in urban settings of Vientiane city, Lao PDR.
    Ndille EE; Dubot-Pérès A; Doucoure S; Mouchet F; Cornelie S; Sidavong B; Fournet F; Remoue F
    Trop Med Int Health; 2014 May; 19(5):576-80. PubMed ID: 24641205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific human antibody responses to Aedes aegypti and Aedes polynesiensis saliva: A new epidemiological tool to assess human exposure to disease vectors in the Pacific.
    Mathieu-Daudé F; Claverie A; Plichart C; Boulanger D; Mphande FA; Bossin HC
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006660. PubMed ID: 30040826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aedes aegypti anti-salivary gland antibody concentration and dengue virus exposure history in healthy individuals living in an endemic area in Colombia.
    Londoño-Rentería B; Cárdenas JC; Giovanni JE; Cárdenas L; Villamizar P; Rolón J; Chisenhall DM; Christofferson RC; Carvajal DJ; Pérez OG; Wesson DM; Mores CN
    Biomedica; 2015; 35(4):572-81. PubMed ID: 26844447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis in a murine model points to IgG responses against the 34k2 salivary proteins from Aedes albopictus and Aedes aegypti as novel promising candidate markers of host exposure to Aedes mosquitoes.
    Buezo Montero S; Gabrieli P; Severini F; Picci L; Di Luca M; Forneris F; Facchinelli L; Ponzi M; Lombardo F; Arcà B
    PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007806. PubMed ID: 31618201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological biomarker for assessing human exposure to Aedes mosquito bites during a randomized vector control intervention trial in northeastern Thailand.
    Fustec B; Phanitchat T; Aromseree S; Pientong C; Thaewnongiew K; Ekalaksananan T; Cerqueira D; Poinsignon A; Elguero E; Bangs MJ; Alexander N; Overgaard HJ; Corbel V
    PLoS Negl Trop Dis; 2021 May; 15(5):e0009440. PubMed ID: 34043621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the human IgG antibody response to Aedes albopictus saliva as a new specific biomarker of exposure to vector bites.
    Doucoure S; Mouchet F; Cornelie S; DeHecq JS; Rutee AH; Roca Y; Walter A; Hervé JP; Misse D; Favier F; Gasque P; Remoue F
    PLoS Negl Trop Dis; 2012; 6(2):e1487. PubMed ID: 22363823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE and IgG4 antibody responses to Aedes saliva in African children.
    Remoue F; Alix E; Cornelie S; Sokhna C; Cisse B; Doucoure S; Mouchet F; Boulanger D; Simondon F
    Acta Trop; 2007; 104(2-3):108-15. PubMed ID: 17825239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to
    Chea S; Willen L; Nhek S; Ly P; Tang K; Oristian J; Salas-Carrillo R; Ponce A; Leon PCV; Kong D; Ly S; Sath R; Lon C; Leang R; Huy R; Yek C; Valenzuela JG; Calvo E; Manning JE; Oliveira F
    Front Immunol; 2024; 15():1368066. PubMed ID: 38751433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between exposure to vector bites and antibody responses to mosquito salivary gland extracts.
    Fontaine A; Pascual A; Orlandi-Pradines E; Diouf I; Remoué F; Pagès F; Fusaï T; Rogier C; Almeras L
    PLoS One; 2011; 6(12):e29107. PubMed ID: 22195000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First attempt to validate human IgG antibody response to Nterm-34kDa salivary peptide as biomarker for evaluating exposure to Aedes aegypti bites.
    Elanga Ndille E; Doucoure S; Damien G; Mouchet F; Drame PM; Cornelie S; Noukpo H; Yamadjako S; Djenontin A; Moiroux N; Misse D; Akogbeto M; Corbel V; Henry MC; Chandre F; Baldet T; Remoue F
    PLoS Negl Trop Dis; 2012; 6(11):e1905. PubMed ID: 23166852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of anti-Aedes aegypti salivary extract antibody concentration to correlate risk of vector exposure and dengue transmission risk in Colombia.
    Londono-Renteria B; Cardenas JC; Cardenas LD; Christofferson RC; Chisenhall DM; Wesson DM; McCracken MK; Carvajal D; Mores CN
    PLoS One; 2013; 8(12):e81211. PubMed ID: 24312537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of exposure to Aedes albopictus bites in mainland France using an immunological biomarker.
    Poinsignon A; Boulanger D; Binetruy F; Elguero E; Darriet F; Gallian P; De Lamballerie X; Charrel RN; Remoue F
    Epidemiol Infect; 2019 Jan; 147():e238. PubMed ID: 31364567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG1 and IgG4 antibodies against Aedes aegypti salivary proteins and risk for dengue infections.
    Cardenas JC; Drame PM; Luque-Burgos KA; Berrio JD; Entrena-Mutis E; González MU; Carvajal DJ; Gutiérrez-Silva LY; Cardenas LD; Colpitts TM; Mores CN; Londono-Renteria B
    PLoS One; 2019; 14(1):e0208455. PubMed ID: 30601814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Field trial on a novel control method for the dengue vector, Aedes aegypti by the systematic use of Olyset® Net and pyriproxyfen in Southern Vietnam.
    Tsunoda T; Kawada H; Huynh TT; Luu LL; Le SH; Tran HN; Vu HT; Le HM; Hasebe F; Tsuzuki A; Takagi M
    Parasit Vectors; 2013 Jan; 6():6. PubMed ID: 23312018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural vertical transmission of dengue viruses by Aedes aegypti in Bolivia.
    Le Goff G; Revollo J; Guerra M; Cruz M; Barja Simon Z; Roca Y; Vargas Florès J; Hervé JP
    Parasite; 2011 Aug; 18(3):277-80. PubMed ID: 21894270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response against saliva antigens of Anopheles gambiae and Aedes aegypti in travellers in tropical Africa.
    Orlandi-Pradines E; Almeras L; Denis de Senneville L; Barbe S; Remoué F; Villard C; Cornelie S; Penhoat K; Pascual A; Bourgouin C; Fontenille D; Bonnet J; Corre-Catelin N; Reiter P; Pagés F; Laffite D; Boulanger D; Simondon F; Pradines B; Fusaï T; Rogier C
    Microbes Infect; 2007 Oct; 9(12-13):1454-62. PubMed ID: 17913537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of dengue and diversity of cultivable bacteria in vector Aedes aegypti (L.) from two dengue endemic districts, Kanchanpur and Parsa of Nepal.
    Thapa S; Pant ND; Shrestha R; Gc G; Shrestha B; Pandey BD; Gautam I
    J Health Popul Nutr; 2017 Feb; 36(1):5. PubMed ID: 28193261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG Antibody Responses to the
    Buezo Montero S; Gabrieli P; Montarsi F; Borean A; Capelli S; De Silvestro G; Forneris F; Pombi M; Breda A; Capelli G; Arcà B
    Front Cell Infect Microbiol; 2020; 10():377. PubMed ID: 32850479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.